Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Diabetes & Metabolism Année : 2020

Dates et versions

hal-04074618 , version 1 (19-04-2023)

Licence

Identifiants

Citer

M. Bretault, C. Carette, R. Zaharia, K. Vychnevskaia, J.-L. Bouillot, et al.. Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma. Diabetes & Metabolism, 2020, 46 (6), pp.514-515. ⟨10.1016/j.diabet.2019.07.004⟩. ⟨hal-04074618⟩
11 Consultations
83 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More